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SUMMARY 
A sample of 805 psychotic patients belonging to different groups was screened for acute hepatic porphyria during 
1975 to 1987 by observing urinary colour change on standing to brown red colour and for positive Waston-Schwartz 
test, indicating increase in urinary porphobilinogen which is diagnostic of acute hepatic porphyria. 27.95% cases 
had shown positivity which was further confirmed by quantitative estimation using spectrophotometric method of 
Rimington. However, when these positive cases were subjected to more specific tests viz, additional butanol extrac-
tion modification to Watson-Schwartz test and quantitative estimation of porphobilinogen by ion-exchange resin 
coloumn chromatographic method of Mauzerall & Grannick, only 1.12% could confirm their positivity. These cases 
were only, diagnosed as acute hepatic porphyria. The positivity to the non specific, yet accepted diagnostic tests 
for acute porphyria observed in remaining 26.8% psychotics was an amazing unexplained phenomenon. It was sug-
gestive of the presence of a non specific porphyric activity. 
Acute porphyria amongst psychotics Was 
first described by Waldenstrom (1937). He 
got most of his cases by a routine survey of 
urine from patients in Swedish mental hos-
pital (Kark, 1955). Goldberg (1959) in a 
study of 50 cases of acute porphyria reported 
six cases who could be legally certified as 
insane; nine cases found to be confused, 
hallucinated and disoriented and another 
14 who were depressed and behaving pecu-
liarly. Mecalpine and Hunter (1966) on 
the basis of retrospective account of urinary 
colour change concluded that insanity of King 
George III, which could be manic depressive 
psychosis, Was due to acute porphyria. There 
are many other workers, who had also re-
ported acute porphyria in psychotics (Saint 
et al., 1954; Peters et al., 1958; Roth et ai., 
1968; Stein & Techudy, 1970). Thus, we 
find that there exist a definite association of 
hepatic porphyria with psychoses. However, 
the extent of this relationship, and how por-
phyria causes psychoses is still ill understood. 
The author came across a significantly high 
number of psychotics, during three screening 
studies (Golechha, 1977; Golechha et al., 
1981 & 1985). The paper presents authors 
experience of finding acute porphyria in 
psychiatric practice specially amongst psy-
chotics studied during last twelve years and 
discusses the problem of biochemical diag-
nosis and various advances made in the field. 
MATERIAL 
Total of 805 psychotic patients from 1975 
to July 1987 were examined for evidence of 
acute porphyria. 689 of them formed the 
part of screening studies for porphyria dur-
ring 1975 to 1981. Another 116 cases of 
psychoses belonging to high suspicion group 
for acute porphyria were also screened. The 
criteria of high suspicion for acute porphyria 
are given in appendix 'A'. It Was evolved 
on the basis of the experience gathered in 
the preceding years. These age ranged 
from 10 to 55 years with mean age of 25.8 
years. Male female ratio was 2.77 : 1. 
Cases in group A, were consecutively 
admitted new cases or first seen in OPD 
irrespective of age, sex and diagnostic sub 
category. The diagnosis was based on 
ICD-9. A matched control of 562 healthy 
volunteers was also screened for better stan-
dardization of results. 
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TABLE I. Test sample sub group, source and number of psychotic patients 
_ Year of 
GrOUP rfudy 
A—1975 
1978 
1979 to 1981 
B—1982 to 1987 
Place 
Military Hospital, Jhansi 
KGMC Lucknow & Command Hospital, Lucknow 
Command Hospital, Lucknow 
Total 
Psychotics with high suspicion of acute porphyria 
studied at Tezpur & Delhi 
Total Psychotics 
Total No. of psychiatric 
patients screened for 
porphyria 
107* 
519** 
890*** 
1516 
Number of 
psychotic 
patients 
19 
305 
365 
689 
116 
805 
•Golechha G. R., 1977; **Golechha et al., 1981; ***Golechha et al., 1985. 
METHODOLOGY 
All patients Were clinically evaluated in 
detail. Cases found positive for porpho-
bilinogen were periodically followed up for 
urinary execretion of porphobilinogen. 
A. Sample collection : Freshly void-
ed urine was collected in clean colourless 
glass containers. The time of collection was 
random. Mostly it was at the time of first 
examination on attending the OPD or on 
admission before any treatment was commen-
ced. In about 153 cases it was not possible 
as the patients were not co-operative and 
were violent. They were tested on subse-
quent days. In three cases catheter sample 
was obtained as patients were in stupor and 
bladder was distended. Seven cases supplied 
plain Water instead of urine for reasons best 
known to them. 
B. Qualitative estimation of por-
phobilinogen : This was done by Waston-
Schwartz Test (Watson & Schwartz, 1941; 
Varley & Gowenlock, 1980) with modifica-
tion of butanol extraction in stages (Watson 
et al., 1961 & 1964). A portable kit Was 
used for immediate testing of urine on 
voiding. An acid control was run parallel 
with each test sample to detect any false 
positive result. The chloroform extractions 
were repeated till no further colour was 
extracted. Tests were repeated during follow-
up in positive cases. 
C. Quantitative estimation for por-
phobilinogen ; It was done in all Watson-
Schwartz Test (W. S. test) positive cases by 
methods of Rimington (1958, 1961) within 
2 to 3 hours on the same samples on which 
W. S. test was already performed. Coloumn 
chromatographic estimations by method of 
Mauzerall & Grannick's (1956) as modified 
by Marvar et al. (1966) were carried out in 
a representative samples which were drawn 
from 3 different groups, positive for Modi-
fied W. S. test (M. W. S. test), only Original 
W. S. Test (O. W. S. test) positive and W. S. 
test negative groups. This Was for com-
parison of findings obtained by Rimington's 
method and to know the difference of values 
between M. W. S. test positive & only O. W. 
S. test, positive samples. 
D. Colour change of urine on stan-
ding s Urine samples were exposed to sun-
light in colourless glass containers for 2 to 
7 days depending on weather and duration 
of sunlight. Any change of colour to brown 
red i.e. port wine or brown red with blackish 
hue i.e. cococola colour was noted. 
E. Fluorescence test: Urine and faeces 
Were seen in ultra violet light using Wood's 
lamp or red fluorescence to find uro & copro ACUTE HEPATIC PORPHYRIA AND PSYCHOSES  321 
porphyrins as described by Rimington 
(1958). 
F. Clinical evaluation : It Was made 
in all cases. History in detail including on-
set, presence of precipitating factors, past 
episodes any significant past and family his-
tory and history of drugs taken during past 
24 hours of urine testing and during pre-
vious 7 days were recorded. Detailed phy-
sical and mental status examination was done. 
Family pedigree of some of the positive cases 
were worked up. 
G. Follow-up study : Follow-up tes-
ting of urine for W. S. test and quantitative 
estimation of porphobilinogen was done once 
a week in positive cases for 4 to 6 weeks. 
There were 82 cases of organic psychoses 
and 723 cases of functional psychoses, ratio 
TABLE II. Number of cases showing Watson-Schwartz test positive 
A—Test sample 
ICD-9 
290.4 
291 
293 
294 
295 
296.0 
296.1 
297 
298 
B—Control 
Diagnosis 
Diagnosis 
Arteriosclerotic Dementia (N=l) 
Alcoholic Psychosis (N=12) 
Transient Organic 
Psychotic Condition (N=44) 
W. S. test  : positive 
Number of cases % J 
Other Organic Psychotic Condition (N=25) 
Schizophrenia (N=505) 
Mania & Hypomania (N=110) 
Depression (N=86) 
Paranoid States (N= 15) 
Acute Paranoid Reaction (N=7) 
Total (N=805) 
Matched control of group B & C 
TABLE III. Urine colour 
1 
2 
10 
8 
148 
28 
23 
3 
2 
225 
562 
change on standing & 
No. of cases showing 
significant colour change 
Alcoholic Psychosis (N=8) 
Transient Orga 
Other Organic 
Schizophrenia ( 
nic Psychosis (N=38) 
Psychosis (N= 18) 
;N=291) 
Mania & Hypomania (N=69) 
Depression (N=  =58) 
Paranoid States (N=12) 
Acute Paranoid Reaction (N=6) 
Total N=500 
2 
14 
5 
114 
24 
20 
3 
2 
184(36.8) 
— 
16.6 
22.7 
32.0 
29.3 
25.4 
26.7 
20.0 
28.5 
27.95 
3.1 
W. S. test positivity 
No. of W. S. test 
positive cases 
1 
9 
4 
101 
19 
17 
3 
1 
155(31) 
M.  . W. S. positive 
Number of cases % 
@ 
— — 
— — 
3 6.8 
3 12.0 
3 0.59 
— — 
— — 
— — 
— _ 
9 1.12 
— — 
No. of cases positive 
for M. W. S. teat 
3 
2 
2 
— 
— 
— 
— 
7 
@ It includes (O. W. S.)—M. W. S. test positive ceses. 322  G. R. GOLECHHA 
TABLE IV. Groupwise positivity W. S. test 
Study group 
I. Screening study 
Group A 
(N=689) 
II. High suspicion criteria cases 
Group B 
(N=116) 
Total Group 
A+B 
(N-805) 
M. W. S. test positive 
(Butanol modification) 
N 
7 
2 
9 
% 
1.02 
1.72 
1.12 
Only 
test 
N 
163 
53 
216 
O. W. S. 
positive 
% 
23.7 
45.7 
26.8 
Total W. S. test 
positive 
N % 
170 24.7 
55 47.4 
225 27.95 
TABLE V. Follow-up estimation PBG by Rimington's method (W. S. test positive cases) 
Initial values of PBG PBG values after 4 weeks 
Diagnosis 
42 
12 
9 
4 
Mean 
8.1 
7.3 
7.6 
7.2 
SD 
3.96 
2.03 
2.78 
2.1 
Mean 
2.3 
2.8 
3.1 
2.4 
SD 
1.3 
1.5 
.87 
1.05 
Schizophrenia 
Mania & Hypomania 
Depression 
Organic Psychoses 
Total  67 7.83 
p<.001 
2.71  2.44  1.2 
TABLE VI. Comparison of porphobilinogen values estimated by the two different methods 
Samples 
(a) O. W. S. positive (N-11) 
Mean 
Sd 
(b) M. W. S. positive (N-2) 
1. 
2. 
(c) O. W. S. negative (N-2) 
1. 
2. 
Rimington's 
method 
PBG/Litre 
8.04 
1.22 
28.05 
30.05 
2.3 
1.24 
Coloumn chromatography @ 
PBG mgm/Lit. 
.91 
.77 
20.07 
21.9 
.54 
.07 
ALA mgm/Lit. 
1.5 
.6 
3.20 
3.5 
.44 
.1 
AA mgm/Lit. 
4.5 
1.01 
5.08 
2.56 
2.56 
2.94 
@ Method of Mauzerall & Grannick's (1956) as modified by Marvar (1966). 
Statistical evaluation for porphobilinogen value in group (a) by two methods reveals—1=16.27, p < .001, r=.04. ACUTE HEPATIC PORPHYRIA AND PSYCHOSES  323 
being 1 :8. 8. Schizophrenia formed the bulk 
of it (62.7%) followed by mania & hypomania 
(14.9%), depression 10.7% & transient 
organic psychoses 5.5%. O. W. S. test was 
found positive in 27.95% of the total sample 
as shown in Table I as compared to 3.1% 
test positive in matched control of healthy 
volunteers (p<.001). Out of these only 9 
cases had given positive result with butanol 
extraction modification of W. S. test forming 
1.12%. 
Diagnostic category of psychotics showing 
W. S. test positive is shown in Table II. 
Gases showing urinary colour change on 
standing is shown in Table III. 
Out of 500 cases belonging to both organic 
and functional psychoses 36.8% had shown 
significant colour change of urine on standing 
which varied from port wine to brown red 
with blackish hue i.e. cococola colour over 
7 days time. In seven cases colour develop-
ment was so intense that it appeared black. 
There was no difference of colour in modi-
fied W. S. test positive and those negative for 
butanol modification but positive for only 
original W. S. test. In 5.8% of cases colour 
change was noticed but W. S. test Were nega-
tive. The colour change was found to occur 
faster in summer and bright sunlight. 
Cases selected after application of high 
suspicion criteria for acute porphyria, as seen 
in group D in Table IV had shown signifi-
cant increase in detection of cases of positive 
Watson-Schwartz test of both types. 
Quantitative estimation by Riming-
ton's methods ; Cases showing only original 
W. S. test positive were found to have por-
phobilinogen by Rimington's method ranging 
from 4 mgm to 18 mgm per litre. Mean being 
9.4 mg/Litre SD = 2.8. In M. W. S. test 
positive samples it ranged from 10 mg to 
30 mg/Litre. Mean being 19.5 mg/Litre 
SD =7.3. No significant difference in the values 
could be found diseasewise, but three cases of 
stupor two of which were catatonic and one 
depression had shown only O. W. S. test 
positive With surprisingly high value of 15 
to 18 mg/Litre. The urine was obtained 
through catheter and tested immediately for 
W. S. test. The laboratory follow-up of 
67 cases after 4 Weeks (Table V) had shown 
reduction in porphobilinogen values by this 
method. The W. S. test was negative at this 
time and there were no colour change in 
urine on standing except late development 
in 9 cases. The patient had shown improve-
ment in their clinical condition. 
Coloumn chromatographic estimation of 
porphobilinogen (PBG), Aminoleyulinic acid 
(ALA) and Amine acetone (AA) was done in 
11 original W. S. test positive samples which 
Were negative for modified test, 2 modified 
test positive and 2 W. S. test negative urine 
samples which is shown in Table VI. PBG 
values by Rimington's method estimated 
simultaneously are also shown for compari-
son. 
PBG estimated by Rimington's method is 
much higher than that estimated by coloumn 
chromatography in O. W. S. positive group. 
Whereas in M. W. S. positive group it cor-
relates better by two methods. 
Ultraviolet fluorescence tests : Re-
sults were in conclusive due to absence of 
strong fluorescence and unfamiliarity with the 
test. It did not contribute to the study. 
Clinical evaluation : Analysis of clinical 
evaluation in O. W. S. positive and M. W. S. 
positive cases reveal no difference. Positi-
vity of butanol modification has no bearing 
on clinical course except that it was found 
more positive (7.3%) in organic psychotic 
condition than in schizophrenia (.59%). 
Out of six organic psychoses cases where 
M.W.S. test was positive two cases presented 
with fleeting neurological symptoms without 
any fixed neurological deficit. They had 
history of pain in abdomen and severe consti-
pation before the onset of delirium. Third 
case was a male muslim mess waiter who 
Was examined for his "drunken behaviour" 
without having taken alcohol or any drug. 324  G. R. GOLECHHA 
He was thought to be a case of acute demy-
elinating syndrome by treating physician. 
He Was referred for his associated behavioural 
abnormality. Fever, exhaustion and redu-
ced calory intake were the probable preci-
pitating factors. Fourth case was of seizure 
who had no relief with phenobarbitone & 
dilantin sodium and developed psychotics 
episode of schizophrenic type and complained 
of abdominal pain. Remaining two cases 
were diagnosed encephalitis. They were refer-
red for management as they became violent 
and aggressive in medical ward. History 
revealed that they were given a course 
of antimalarial for the febrile illness without 
any proof of malaria and were delerious. 
The three cases of schizophrenia who had 
positive M.W.S. test gave history of pain 
in abdomen. They exhibited the delusion of 
being poisoned and had hallucinations, pas-
sivity and persecution more prominent. 
In the O.W.S. positive group there were 
seven cases belonging to transient organic 
psychosis. They presented with toxic con-
fusional state of unknown etiology. Precipi-
tation by drugs Was found in 6 cases, in 3 
due to barbiturate, in one due to sulpha and 
other two by chloroquine and other anti-
malarial. Five cases with other psychotic 
condition included epileptic psychosis, En-
cephalitis and metabolic encephalopathy, 
who were referred for their abnormal beha-
viour. Curiously one case Was of hypotha-
lamic syndrome who had shown partial 
improvement without any specific treatment. 
The largest number of O.W.S. positive test 
cases Were of schizophrenia. About 70% 
of these cases had acute onset, hallucinatory 
behaviour and complained of somatic 
symptoms viz aches or pain, abdominal and 
non abdominal. About 40% had catatonic 
features. Passivity and persecutory ideas 
were present in 50% of them. 30% had 
belief of having been given something to eat 
in the food or thought that they are being 
poisoned. All of these cases had shown 
evidence of autonomic neuropathy. Eight 
percent had shown presence of one or more 
precipitating factor as listed in appendix. 
Drug history : It revealed about 
479 cases in test sample of 805 had taken/ 
been given some or other drugs during past 
7 days. Only 300 had taken drugs during 
last 24 hours before examination/testing. 
Details of drug could not be established in 
about 200 cases. Phenothiazine and butyro-
phenone group of drugs Were taken by 216, 
benzodiazepine in 200 and antidepressants in 
86 cases. Many patients had more than 
one drug. There were more test negative 
results in patients receiving phenothiazine 
and other psychotropic drugs than in those 
who did not take them. Ratio of positivity 
was 1 :1.9. 
Family screening : No history of diag-
nosed case of porphyria could be found in 
any of our positive M.S.W. or O.W.S. cases. 
37 cases gave history of psychotic disorder 
in their first degree relatives. Family his-
tory of neurological disorders i.e. paralysis 
and seizure were found in 13 cases and recur-
ring pain abdomen in 19 cases. 69 first 
degree relations of 13 positive O-W.S. and 2 
positive M.S.W. cases were screened by 
Rimington's method. Only O.S.W. test was 
found +ve in 37 of them. Modified W.S. 
test was negative in all of them. Even 7 
relation of the two M.W.S. positive cases had 
shown only O.W.S. test positive. All of them 
Were asymptomatic and had no history of 
any past episode. 
Amino Acetone : Table VI shows 
high values of amino acetone in urine of 
O.W.S. positive psychotics as compared to 
normals and values of porphobilinogen 
found in their own urine by coloumn chro-
matography. Role of Amino Acetone, an 
aminoketone, in biological fluids is still not 
well understood and needs further research 
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DISCUSSION 
Mental changes are an important mani-
festations of acute porphyria and have been 
described by Markovitz in U. S. A. (1954), 
Waldenstrom in Sweden (1957), Goldberg 
in U. K. (1959) and Eales in S. Africa (1962) 
varying from 50 to 80%, in their patients 
of acute porphyria. Kaelbling et al. (1961) 
had reported 35 positive cases amongst psy-
chiatric patients screened in Ohio. Ten had 
Schizophrenia, two had psychotic depression 
and ten cases Were diagnosed as acute or 
chronic brain syndrome. They concluded 
that psychiatric disorder may be the only 
manifestation of porphyria. Peters et al. 
(1958) described porphyric schizophrenic 
syndrome when they found positive Watson-
Schwartz test in the urine of schizophrenics. 
The evidence of porphyric activity in psy-
chotics Was further established by the work 
of Peter et al. (1985) when they found dimi-
nished PBG deaminase activity in the ery-
throcytes of 70 individuals forming 1.8% of 
the total sample from 2 psychiatric hospitals 
in U. S. A. But in their final analysis they 
diagnosed only -21% as cases of acute 
porphyria on the basis of increased PBG 
by Mauzerall & Grannick's method. 
In this 12 years study if we exclude the 
high suspicion group, then psychotic forms 
45.45% of total psychiatric patients population 
of 1516 who were screened, out of which 
1.02% could be diagnosed as cases of acute 
porphyria as their modified W. S. test was 
positive and quantitative estimation of true 
porphobilinogen Was also high as found 
by coloumn chromatographic method of 
Mauzerall & Grannick, modified by Marvar 
(1966). On the same testing criteria this 
percentage increased to 1.7% in group D 
where We adopted high suspicion criteria for 
acute porphyria in selecting the case for por-
phyria testing. What is more astonishing 
is that the group of only original W. S. test 
positive cases which formed 23.7% of our 
test sample of psychotics. In group D this 
has risen to 45.7% when high suspicion 
criteria of selecting cases for acute porphyria 
testing was adopted. These O.W.S. positive 
cases could have been accepted as cases of 
acute porphyria before 1961. When finding 
too many W. S. test positive cases Watson 
et al. (1961, 1964) advocated butanol modi-
fication to weed out false positive results 
and emphasis was laid on isolation of por-
phobilinogen on ion exchange resin and then 
quantifying it as per the method of Mauzerall 
& Grannick. As a corollary to these addi-
tions very rightly, We find significant decrease 
in reporting of acute porphyria cases in the 
world literature. Our study is unique in 
the sense that we adopted, apart from clinical 
evaluation, three different objective para-
meter for finding evidence of porphyria in 
our patients. The first one was the recording 
colour change of urine on standing to brown 
red i.e. port wine colour. Though clumsy 
and crude test, it was equally useful in a 
clinical setting to indicate probable evidence 
of acute porphyria. The colour change 
occurs due to enzymic and nonenzymic con-
version of porphobilinogen into porphobilin 
and uroporphyrin (Watson & Schwartz, 1941; 
Waldenstrom, 1957; Dean, 1971; Elder, 
1980). There is no large scale study which 
has reported on this aspect of porphyria. 
The second parameter used Was original 
W. S. test done in stages using N. acetate as 
buffer before the chloroform extraction. 
An acid control Was run parallel with each 
test. Chloroform extraction was repeated 
till no further colour could be extracted. 
The recording of drug history and its 
relation to test positivity further helped in 
ruling out the positivity simply on account 
of drugs (McEwen & Patterson, 1972). 
Thus false positivity of Watson-Schwartz 
test was cautiously guarded. The third 
objective parameter used was quantification 
of porphobilinogen by spectrophotometric 
estimation by Rimington's method in all 
W. S. test positive cases initially, and in some 326  G. R. GOLECHHA 
on follow-up after 4 weeks. In about 30% 
(67) ofO.W.S. positive cases, finding of decre-
ased value of porphobilinogen after treatment 
for 4 weeks corresponding to clinical reco-
very of the patient was a significant observa-
tion (Table VI). When we look at the 
coloumn chromatographic estimation of 
porphobilinogen (Table VI) it becomes 
very clear that porphobilinogen isolated and 
estimated by Mauzerall & Grannick's method 
is that, whose aldehyde compound is insoluble 
both in chloroform and in butanol as seen 
in positive modified W. S. test. The fact 
which is accepted and applauded by part of 
scientific community (BMJ, 1975). Yet, 
some authorities (Varley, 1980 and Elder 
1980) do not recommend this butanol modi-
fication to original W. S. test even after 20 
years of its advocation by Watson et al. 
(1961, 1964). This proves the grey zones 
and dilemma of research in this field. Obvi-
ously there appears to be more than one 
biochemical entity which is branded singly 
as porphobilinogen. This concept is shared 
by many pioneer workers in this field viz 
Watson et al. (1961, 1964) and Irvin (1974, 
1978). They think that there are some 
other intermediatory products like various 
porphyrinogens, other monopyroles i.e. kryp-
topyrrole and its lactum, different isomers of 
porphobilinogen, polypyrroles and certain 
indoles (Ludwing, 1958) which may be 
responsible in causing the clinical manifestat-
ion of disorder and may give positive original 
Watson-Schwartz test but are negative for 
butanol extraction. Thus, this concept of 
the presence of other Ehrlich's aldehyde com-
pounds indicating non specific porphyric 
activity is an accepted one. The forgoing 
view is further strengthened by the study of 
Ackner et al. (1961) who found no correla-
tion between excretion of porphobilinogen as 
estimated by Mauzerall & Grannick method, 
with the clinically manifest symptomatology, 
as some patients were symptom less despite 
excreting considerable quantities of porpho-
bilinogen, whilst other had symptoms with-
out any increase in urinary porphobilinogen 
as tested by this method. Further it has 
been shown that administration of this speci-
fic stable type of porphobilinogen in the body 
did not produce any clinical disorder in 
animals and human volunteers (Goldberg 
etal., 1954). It brings out the significance of 
non specific porphyric activity in causation 
of manifest symptomatology which is detec-
ted only by non specific original W. S. test 
and estimated quantitatively by Rimington's 
method and missed by more specific testing. 
Thus we find that these 23.7% of original 
W. S. test positive psychotic cases in our 
study could have been diagnosed as porphyria 
by past non specific testing criteria followed 
by Waldenstrom (1957) and other pioneer 
Workers viz Goldberg (1959) and Eales (1962). 
But We restrained to do so. However, the 
fact of presence of porphyric activity in these 
cases can not be denied. The evidence of 
this porphyric activity found practically in 
equal proportion as a common denominator 
in all types of functional psychoses and some 
of the organic psychoses, indicates that it 
may be one of the many missing links in still 
ill understood etiopathology of the various 
psychotic disorders whose symptomatology is 
reversible similar to acute porphyria and 
responds to chloropromazine (Melby et al., 
1956) 
The study shows a close association bet-
ween psychoses and acute hepatic porphyria. 
Till further exploration, non specific tests 
like urinary colour change on standing, ori-
ginal Watson-Schwartz test and quantita-
tive estimation by Rimington's method 
should be adopted as indicator of porphyria 
activity without going into biochemical con-
troversy of true stable form of porphobi-
linogen or transient unstable other Ehrlich's 
aldehyde reactors, if We do not wish to miss 
the clinical case material with porphyric 
activity. Any research on psychoses should 
include these parameters and others to assess ACUTE HEPATIC PORPHYRIA AND PSYCHOSES  327 
the extent of porphyric activity, as they may 
have contributed to some extent in develop-
ing the psychotics process. These tests can 
also serve objective means to monitor clinical 
improvement in cases of psychoses and may 
have predictive values. Entity of acute 
porphyria must be kept in mind whenever 
high suspicion criteria as given in appendix 
are fulfilled, while dealing with psychotics 
or psychiatric patients in general. 
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Appendix 'A' 
Criteria for High Suspicion of Acnte Porphyria in a Psychotic Patient 
History or presence of any one factor from group 'A' and two from group 'B' in a psychotics was considered to 
be indicative of high suspicion for Acute Porphyria. 
Group A 
1. Unexplained recurring abdominal pain-acute colicky, subacute or chronic diffuse and non specific. 
2. Unexplained neurological symptoms-paresis, paralysis, paraesthesia and seizures. 
3. Precipitation by barbiturates, sulphas, chloroquine and other antimalarials. 
4. Past and family history of porphyria. 
5. Passing of red coloured urine (with no lab evidence of blood) or urine changing to brown red colour on stan-
ding. 
6. Unexplained altered level of consciousness including stupor. 
Group B 
1. Acute onset (upto seven days). 
2. Unexplained non abdominal pains and aches. 
3. Skin lesions-photo sensitivity, pigmentation, burning, stinging, urticarial swellings, bullae and blisters. 
4. Evidence of autonomic neuropathy by any two of the follow Tachicardia (Pulse > 90/mt) or Bradicardia 
(Pulse <60/mt) Hypertension—B. P. systolics> 150 mm, diastolics > 90 mm, Constipation > 72 hours. 
Unexplained diarrhoea or vomitings. 
Unexplained giddiness. 
Precipitation by any two—exhaustion, starvation, infection, fever, trauma (surgical or non surgical) mens-
turation or pregnancy in females. Drugs other than listed in group A e.g. contraceptive pills, Isonex, Griseo-
flavin or others known to have porphyrogenic activity. 
5. 